As filed with the Securities and Exchange Commission on September 16, 1996
Registration No. 33-6877
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------------
Post Effective Amendment No. 10
to
Form S-1
on
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
-------------------------------
UNIGENE LABORATORIES, INC.
(Exact name of Registrant as specified in its charter)
-------------------------------
Delaware 22-2328609
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
-------------------------------
110 Little Falls Road
Fairfield, New Jersey 07004
(201) 882-0860
(Address, including zip code, and telephone number, including
area code, of Registrant's principal executive offices)
-------------------------------
Warren P. Levy, President
Unigene Laboratories, Inc.
110 Little Falls Road
Fairfield, New Jersey 07004
(201) 882-0860
(Name, address, including zip code, telephone number, including
area code, of agent for service)
-------------------------------
Copy to:
Jesse Margolin, Esq.
Becker Ross Stone DeStefano & Klein
317 Madison Avenue, Suite 1410
New York, NY 10017-5372
-------------------------------
<PAGE>
If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. [ ]
If any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under the
Securities Act of 1933, other than securities offered only in connection with
dividend or interest reinvestment plans, check the following box. [ ]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offer. [ ]
If this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list the Securities
Act registration statement number on the earlier effective registration
statement for the same offering. [ ]
If delivery of the prospectus is expected to be made pursuant to Rule
434, please check the following box. [ ]
<PAGE>
Prospectus
UNIGENE LABORATORIES, INC.
7,982,177 Shares of Common Stock
(par value $.01 per share)
7,982,177 shares of common stock, $.01 par value per share ("Common
Stock") were offered under this Registration Statement, which were issuable upon
the exercise of outstanding Redeemable Class B Common Stock Purchase Warrants
("Class B Warrants"). The registered holder of each Class B Warrant was entitled
to purchase 1.4269 shares of Common Stock at $3.504 per share on or prior to
September 10, 1996. The Class B Warrants expired on September 10, 1996.
Accordingly, the Company is hereby removing from registration the said 7,982,177
shares of Common Stock.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-3 and has duly caused this registration
statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in Fairfield, New Jersey, on the 16th day of September, 1996.
UNIGENE LABORATORIES, INC.
By /s/ WARREN P. LEVY
Warren P. Levy, President
Pursuant to the requirements of the Securities Act of 1933, as amended,
this registration statement has been signed below by the following persons in
the capacities and on the dates indicated:
Signature Title Date
- --------- ----- ----
/s/ WARREN P. LEVY Director, President (principal September 16, 1996
- ------------------ executive officer)
Warren P. Levy
/s/ RONALD S. LEVY Director, Vice President September 16, 1996
- ------------------
Ronald S. Levy
/s/ JAY LEVY Chairman of the Board of Directors, September 16, 1996
- ------------ Treasurer (principal financial and
Jay Levy accounting officer)
* Director September 16, 1996
- ------------
Robert Ruark
* Director September 16, 1996
- ------------
George M. Weimer
*By /s/ RONALD S. LEVY
- ----------------------
(Ronald S. Levy)
Attorney-in-fact
September 16, 1996
